276 related articles for article (PubMed ID: 30408427)
1. Lost in the crowd: identifying targetable MHC class I neoepitopes for cancer immunotherapy.
Wilson EA; Anderson KS
Expert Rev Proteomics; 2018 Dec; 15(12):1065-1077. PubMed ID: 30408427
[TBL] [Abstract][Full Text] [Related]
2. Recent Advances in Lung Cancer Immunotherapy: Input of T-Cell Epitopes Associated With Impaired Peptide Processing.
Leclerc M; Mezquita L; Guillebot De Nerville G; Tihy I; Malenica I; Chouaib S; Mami-Chouaib F
Front Immunol; 2019; 10():1505. PubMed ID: 31333652
[TBL] [Abstract][Full Text] [Related]
3. Mass spectrometry driven exploration reveals nuances of neoepitope-driven tumor rejection.
Ebrahimi-Nik H; Michaux J; Corwin WL; Keller GL; Shcheglova T; Pak H; Coukos G; Baker BM; Mandoiu II; Bassani-Sternberg M; Srivastava PK
JCI Insight; 2019 Jun; 5(14):. PubMed ID: 31219806
[TBL] [Abstract][Full Text] [Related]
4. Identification of neoepitope reactive T-cell receptors guided by HLA-A*03:01 and HLA-A*11:01 immunopeptidomics.
Ade CM; Sporn MJ; Das S; Yu Z; Hanada KI; Qi YA; Maity T; Zhang X; Guha U; Andresson T; Yang JC
J Immunother Cancer; 2023 Sep; 11(9):. PubMed ID: 37758652
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of expressed HLA-binding breast cancer neoepitopes for potential use in individualized cancer therapy.
Reimann H; Nguyen A; Sanborn JZ; Vaske CJ; Benz SC; Niazi K; Rabizadeh S; Spilman P; Mackensen A; Ruebner M; Hein A; Beckmann MW; van der Meijden ED; Bausenwein J; Kretschmann S; Griffioen M; Schlom J; Gulley JL; Lee KL; Hamilton DH; Soon-Shiong P; Fasching PA; Kremer AN
J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34172517
[TBL] [Abstract][Full Text] [Related]
6. Prediction of cancer neoepitopes needs new rules.
Brennick CA; George MM; Srivastava PK; Karandikar SH
Semin Immunol; 2020 Feb; 47():101387. PubMed ID: 31952902
[TBL] [Abstract][Full Text] [Related]
7. The neoepitope landscape of breast cancer: implications for immunotherapy.
Narang P; Chen M; Sharma AA; Anderson KS; Wilson MA
BMC Cancer; 2019 Mar; 19(1):200. PubMed ID: 30832597
[TBL] [Abstract][Full Text] [Related]
8. Neoepitopes as cancer immunotherapy targets: key challenges and opportunities.
Brennick CA; George MM; Corwin WL; Srivastava PK; Ebrahimi-Nik H
Immunotherapy; 2017 Mar; 9(4):361-371. PubMed ID: 28303769
[TBL] [Abstract][Full Text] [Related]
9. Cancer Neoepitopes for Immunotherapy: Discordance Between Tumor-Infiltrating T Cell Reactivity and Tumor MHC Peptidome Display.
Wickström SL; Lövgren T; Volkmar M; Reinhold B; Duke-Cohan JS; Hartmann L; Rebmann J; Mueller A; Melief J; Maas R; Ligtenberg M; Hansson J; Offringa R; Seliger B; Poschke I; Reinherz EL; Kiessling R
Front Immunol; 2019; 10():2766. PubMed ID: 31921104
[TBL] [Abstract][Full Text] [Related]
10. A Recurrent Mutation in Anaplastic Lymphoma Kinase with Distinct Neoepitope Conformations.
Toor JS; Rao AA; McShan AC; Yarmarkovich M; Nerli S; Yamaguchi K; Madejska AA; Nguyen S; Tripathi S; Maris JM; Salama SR; Haussler D; Sgourakis NG
Front Immunol; 2018; 9():99. PubMed ID: 29441070
[TBL] [Abstract][Full Text] [Related]
11. Population-level distribution and putative immunogenicity of cancer neoepitopes.
Wood MA; Paralkar M; Paralkar MP; Nguyen A; Struck AJ; Ellrott K; Margolin A; Nellore A; Thompson RF
BMC Cancer; 2018 Apr; 18(1):414. PubMed ID: 29653567
[TBL] [Abstract][Full Text] [Related]
12. Immunization with short peptide particles reveals a functional CD8
He X; Zhou S; Dolan M; Shi Y; Wang J; Quinn B; Jahagirdar D; Huang WC; Tsuji M; Pili R; Ito F; Ortega J; Abrams SI; Ebos JML; Lovell JF
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34862254
[TBL] [Abstract][Full Text] [Related]
13. Targeting Neoepitopes to Treat Solid Malignancies: Immunosurgery.
de Sousa E; Lérias JR; Beltran A; Paraschoudi G; Condeço C; Kamiki J; António PA; Figueiredo N; Carvalho C; Castillo-Martin M; Wang Z; Ligeiro D; Rao M; Maeurer M
Front Immunol; 2021; 12():592031. PubMed ID: 34335558
[TBL] [Abstract][Full Text] [Related]
14. ISOTOPE: ISOform-guided prediction of epiTOPEs in cancer.
Trincado JL; Reixachs-Solé M; Pérez-Granado J; Fugmann T; Sanz F; Yokota J; Eyras E
PLoS Comput Biol; 2021 Sep; 17(9):e1009411. PubMed ID: 34529669
[TBL] [Abstract][Full Text] [Related]
15. Novel tools to assist neoepitope targeting in personalized cancer immunotherapy.
Saini SK; Rekers N; Hadrup SR
Ann Oncol; 2017 Dec; 28(suppl_12):xii3-xii10. PubMed ID: 29092006
[TBL] [Abstract][Full Text] [Related]
16. Predicting T cell recognition of MHC class I restricted neoepitopes.
Koşaloğlu-Yalçın Z; Lanka M; Frentzen A; Logandha Ramamoorthy Premlal A; Sidney J; Vaughan K; Greenbaum J; Robbins P; Gartner J; Sette A; Peters B
Oncoimmunology; 2018; 7(11):e1492508. PubMed ID: 30377561
[TBL] [Abstract][Full Text] [Related]
17. Characterizing neoantigens for personalized cancer immunotherapy.
Capietto AH; Jhunjhunwala S; Delamarre L
Curr Opin Immunol; 2017 Jun; 46():58-65. PubMed ID: 28478383
[TBL] [Abstract][Full Text] [Related]
18. Thermostability profiling of MHC-bound peptides: a new dimension in immunopeptidomics and aid for immunotherapy design.
Jappe EC; Garde C; Ramarathinam SH; Passantino E; Illing PT; Mifsud NA; Trolle T; Kringelum JV; Croft NP; Purcell AW
Nat Commun; 2020 Dec; 11(1):6305. PubMed ID: 33298915
[TBL] [Abstract][Full Text] [Related]
19. T Cell Epitope Prediction and Its Application to Immunotherapy.
Schaap-Johansen AL; Vujović M; Borch A; Hadrup SR; Marcatili P
Front Immunol; 2021; 12():712488. PubMed ID: 34603286
[TBL] [Abstract][Full Text] [Related]
20. Induction of neoantigen-reactive T cells from healthy donors.
Ali M; Foldvari Z; Giannakopoulou E; Böschen ML; Strønen E; Yang W; Toebes M; Schubert B; Kohlbacher O; Schumacher TN; Olweus J
Nat Protoc; 2019 Jun; 14(6):1926-1943. PubMed ID: 31101906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
